Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Whole breast radiotherapy in cN0 early breast cancer patients with pathological sentinel lymph nodes (pN1mic, pN1a) without axillary dissection: preliminary results of the observational LISEN trial.
Ursini LA, Nuzzo M, Rosa C, Borgia M, Caravatta L, Di Tommaso M, Trignani M, Di Guglielmo FC, Ausili Cefaro G, Angelucci D, Muzi M, Martino G, Cianchetti E, Grossi S, Tavoletta S, Brocco D, Grassadonia A, Tinari N, Gildetti S, D'Ostilio N, Stuppia L, Porreca A, Di Nicola M, Genovesi D. Ursini LA, et al. Among authors: d ostilio n. Strahlenther Onkol. 2022 Jul;198(7):612-621. doi: 10.1007/s00066-022-01944-z. Epub 2022 May 2. Strahlenther Onkol. 2022. PMID: 35499695 Free PMC article.
Speed rate (SR) as a new dynamic index of melanoma behavior.
Gualdi G, Panarese F, Meogrossi G, Marchioni M, De Tursi M, Di Marino P, Angelucci D, Amatetti M, Proietto G, Di Nicola M, Amerio P; GICO Melanoma Group. Gualdi G, et al. Pigment Cell Melanoma Res. 2020 Sep;33(5):709-718. doi: 10.1111/pcmr.12890. Epub 2020 Jun 11. Pigment Cell Melanoma Res. 2020. PMID: 32406598
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial.
Pizzuti L, Barba M, Mazzotta M, Krasniqi E, Maugeri-Saccà M, Gamucci T, Berardi R, Livi L, Ficorella C, Natoli C, Cortesi E, Generali D, La Verde N, Cassano A, Bria E, Moscetti L, Michelotti A, Adamo V, Zamagni C, Tonini G, Sergi D, Marinelli D, Paoletti G, Tomao S, Botticelli A, Marchetti P, Tinari N, Grassadonia A, Valerio MR, Mirabelli R, Fabbri MA, D'Ostilio N, Veltri E, Corsi D, Garrone O, Paris I, Sarobba G, Meattini I, Pistelli M, Giotta F, Lorusso V, Garufi C, Russo A, Cazzaniga M, Del Medico P, Roselli M, Vaccaro A, Perracchio L, di Benedetto A, Daralioti T, Sperduti I, De Maria R, Di Leo A, Sanguineti G, Ciliberto G, Vici P. Pizzuti L, et al. Among authors: d ostilio n. Sci Rep. 2021 Jul 2;11(1):13770. doi: 10.1038/s41598-021-92774-z. Sci Rep. 2021. PMID: 34215766 Free PMC article.
Prognostic value of a novel interferon-inducible 90K tumor antigen.
D'Ostilio N, Natoli C, Grassadonia A, Rossi N, Di Stefano P, Amatetti C, Tinari N, Iacobelli S. D'Ostilio N, et al. Ann N Y Acad Sci. 1996 Apr 30;784:288-93. doi: 10.1111/j.1749-6632.1996.tb16243.x. Ann N Y Acad Sci. 1996. PMID: 8651577 No abstract available.
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting.
Pizzuti L, Krasniqi E, Sperduti I, Barba M, Gamucci T, Mauri M, Veltri EM, Meattini I, Berardi R, Di Lisa FS, Natoli C, Pistelli M, Iezzi L, Risi E, D'Ostilio N, Tomao S, Ficorella C, Cannita K, Riccardi F, Cassano A, Bria E, Fabbri MA, Mazzotta M, Barchiesi G, Botticelli A, D'Auria G, Ceribelli A, Michelotti A, Russo A, Salimbeni BT, Sarobba G, Giotta F, Paris I, Saltarelli R, Marinelli D, Corsi D, Capomolla EM, Sini V, Moscetti L, Mentuccia L, Tonini G, Raffaele M, Marchetti L, Minelli M, Ruggeri EM, Scavina P, Bacciu O, Salesi N, Livi L, Tinari N, Grassadonia A, Fedele Scinto A, Rossi R, Valerio MR, Landucci E, Stani S, Fratini B, Maugeri-Saccà M, De Tursi M, Maione A, Santini D, Orlandi A, Lorusso V, Cortesi E, Sanguineti G, Pinnarò P, Cappuzzo F, Landi L, Botti C, Tomao F, Cappelli S, Bon G, Pelle F, Cavicchi F, Fiorio E, Foglietta J, Scagnoli S, Marchetti P, Ciliberto G, Vici P. Pizzuti L, et al. Among authors: d ostilio n. Ther Adv Med Oncol. 2021 Nov 29;13:17588359211059873. doi: 10.1177/17588359211059873. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 35173816 Free PMC article.
Rising incidence of late stage breast cancer after COVID-19 outbreak. Real-world data from the Italian COVID-DELAY study.
Mentrasti G, Cantini L, Vici P, D'Ostilio N, La Verde N, Chiari R, Paolucci V, Crocetti S, De Filippis C, Pecci F, Di Lisa FS, Traisci D, Cona MS, Nicolardi L, Pizzuti L, Gildetti S, Oldani S, Della Mora A, Bruno Rocchi ML, Berardi R. Mentrasti G, et al. Among authors: d ostilio n. Breast. 2022 Oct;65:164-171. doi: 10.1016/j.breast.2022.08.007. Epub 2022 Aug 18. Breast. 2022. PMID: 35998429 Free PMC article.
Early prediction of resistance to tyrosine kinase inhibitors by plasma monitoring of EGFR mutations in NSCLC: a new algorithm for patient selection and personalized treatment.
Buttitta F, Felicioni L, Lorito AD, Cortellini A, Irtelli L, Brocco D, Marino PD, Traisci D, D'Ostilio N, Paolo AD, Malorgio F, Assalone P, Felice SD, Fabbri F, Cianci G, Tursi M, Marchetti A. Buttitta F, et al. Among authors: d ostilio n. Oncotarget. 2020 Mar 17;11(11):982-991. doi: 10.18632/oncotarget.27517. eCollection 2020 Mar 17. Oncotarget. 2020. PMID: 32215186 Free PMC article.
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting.
Pizzuti L, Krasniqi E, Barchiesi G, Della Giulia M, Izzo F, Sanguineti G, Marchetti P, Mazzotta M, Giusti R, Botticelli A, Gamucci T, Natoli C, Grassadonia A, Tinari N, Iezzi L, Tomao S, Tomao F, Tonini G, Santini D, Astone A, Michelotti A, De Angelis C, Mentuccia L, Vaccaro A, Magnolfi E, Gelibter A, Magri V, Cortesi E, D'Onofrio L, Cassano A, Rossi E, Cazzaniga M, Moscetti L, Omarini C, Piacentini F, Fabbri MA, Scinto AF, Corsi D, Carbognin L, Bria E, La Verde N, Samaritani R, Garufi C, Barni S, Mirabelli R, Sarmiento R, Veltri EM, D'Auria G, Paris I, Giotta F, Lorusso V, Cardillo F, Landucci E, Mauri M, Ficorella C, Roselli M, Adamo V, Ricciardi GRR, Russo A, Berardi R, Pistelli M, Fiorio E, Cannita K, Sini V, D'Ostilio N, Foglietta J, Greco F, Zamagni C, Garrone O, Di Cocco B, Baldini E, Livi L, Desideri I, Meattini I, Sarobba G, Del Medico P, De Tursi M, Generali D, De Maria R, Risi E, Ciliberto G, Sperduti I, Villa A, Barba M, Di Leo A, Vici P. Pizzuti L, et al. Among authors: d ostilio n. Int J Cancer. 2020 Apr 1;146(7):1917-1929. doi: 10.1002/ijc.32583. Epub 2019 Aug 7. Int J Cancer. 2020. PMID: 31330065 Free PMC article.
18 results